Abstract:Ethnopharmacological relevance: Ginseng (Panax ginseng C. A. Meyer), a traditional Chinese medicine, is widely used in the adjunctive therapy of the liver diseases. Aim of the study: Ginsenosides are one kind of the main active ingredients in ginseng. Although hepatoprotective mechanisms of ginsenosides, such as anti oxidation, anti-inflammation and anti-apoptosis, have been well studies, little is known about the effect of ginsenosides on drug metabolism in liver. Since CYP3A11/3A4 is a major enzyme catalyzing the drug metabolism in liver, an investigation of the enzyme's expression during the progression of a liver disease will gain valuable information about the hepatic drug metabolism. The purpose of this study was to determine the effect of ginsenosides on the expression of hepatic CYP3A11/3A4 in the lipopolysaccharides (LPS) injured human HepG2 cells and mice. We hypothesize that ginsenosides are important to stabilize CYP3A11/3A4 expression in an injured liver. Materials and methods: In this study, LPS was intraperitoneally intermittently injected to induce the liver injury in mice. Ginsenosides were intragastrically administered to mice for 7 days to treat the liver injury. Serum biochemical analysis and histopathological study were taken to evaluate the hepatoprotective effect of ginsenosides. The effect of ginsenosides was also evaluated in human HepG2 cells in the presence and absence of LPS. Real-time PCR and western blotting method were used to detect the mRNA and protein levels of CYP3A11/3A4 in mouse liver tissue and human HepG2 cells. The reporter gene-transfected cells were used to identify upstream targets in HepG2 cells. Results: LPS injection in mice resulted in the up-regulation of pro-inflammatory cytokines such as IL-6 and TNF-a in liver, up-regulation of hepatic enzymes such as Tbil, ALT, AST and ALP in serum, and down-regulation of CYP3A11/3A4 expression in liver. Ginsenosides treatment reversed the up-regulation of pro inflammatory cytokines and serum hepatic enzymes elicited by LPS. Pathological results suggest that ginsenosides reduced liver damage. Moreover, ginsenosides reversed the decrease of CYP3A11/3A4 expression in the liver of LPS-injured mouse and in LPS-treated HepG2 cells. To further investigate the regulatory mechanisms, we found that ginsenosides enhanced the rifampicin-induced pregnane X receptor (PXR) transactivation of the CYP3A4 promoter. Treatment of hPXR over-expressed cells with ginsenosides increased the rifampicin-inducible expression of CYP3A4 in a concentration-dependent manner. Conclusion: Ginsenosides reverse the effects of LPS-induced hepatic CYP3A11/3A4 dysfunction, suggesting that the stabilization of the CYP3A11/3A4 expression in an injured liver appears a novel hepatoprotective mechanism of ginsenosides.

The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity.

Ginsenoside Metabolites, Rather Than Naturally Occurring Ginsenosides, Lead to Inhibition of Human Cytochrome P450 Enzymes

Structure-activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes.

Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity

Influence of Ginsenoside Rh-1 and F-1 on Human Cytochrome P450 Enzymes

Ginsenoside Metabolites Inhibit P-Glycoprotein in Vitro and in Situ Using Three Absorption Models

Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides.

Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species

Molecular Mechanisms Governing Different Pharmacokinetics of Ginsenosides and Potential for Ginsenoside-Perpetrated Herb-Drug Interactions on Oatp1b3

Lability of Traditional Chinese Medicine by Intestinal Bacterial Metabolism Results in P450 Cycle-mediated Drug-Drug Interaction

The Inhibitory Effect of 20(S)-Protopanaxatriol (ppt) Towards Ugt1a1 and Ugt2b7

Ginseng Disrupts the Metabolism of Cerebrovascular Treatment Drug Clopidogrel

Suppression Of Hepatic Cyp1a2 By Total Ginsenosides In Lipopolysaccharide-Treated Mice And Primary Mouse Hepatocytes

Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

EFFECTS OF INDIVIDUAL GINSENOSIDES, GINKGOLIDES AND FLAVONOIDS ON CYP2C19 AND CYP2D6 ACTIVITY IN HUMAN LIVER MICROSOMES

Effects of 20 Chinese Patent Medicines on the Catalytic Activities of Five Main Cytochrome P450s of Human Liver Microsome

Microsomal Cytochrome P450-Mediated Metabolism of Protopanaxatriol Ginsenosides: Metabolite Profile, Reaction Phenotyping, and Structure-Metabolism Relationship.

A Pharmacokinetic and Pharmacodynamic Study of Drug-Drug Interaction Between Ginsenoside Rg1, Ginsenoside Rb1 and Schizandrin after Intravenous Administration to Rats

Reversing Effects of Ginsenosides on LPS-induced Hepatic CYP3A11/3A4 Dysfunction Through the Pregnane X Receptor.

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of<i>Panax ginseng</i>

Inhibitory Effects of Phytochemicals on Metabolic Capabilities of CYP2D6()1 and CYP2D6()10 Using Cell-Based Models in Vitro.